| Randomized assessment of rapid endovascular treatment of ischemic stroke M Goyal, AM Demchuk, BK Menon, M Eesa, JL Rempel, J Thornton, ... New England Journal of Medicine 372 (11), 1019-1030, 2015 | 7074 | 2015 |
| Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ... The Lancet Neurology 12 (8), 822-838, 2013 | 5599* | 2013 |
| Variants conferring risk of atrial fibrillation on chromosome 4q25 DF Gudbjartsson, DO Arnar, A Helgadottir, S Gretarsdottir, H Holm, ... Nature 448 (7151), 353-357, 2007 | 1119 | 2007 |
| Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke JL Saver, GC Fonarow, EE Smith, MJ Reeves, MV Grau-Sepulveda, ... Jama 309 (23), 2480-2488, 2013 | 1072 | 2013 |
| Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association DT Lackland, EJ Roccella, AF Deutsch, M Fornage, MG George, ... Stroke 45 (1), 315-353, 2014 | 1016* | 2014 |
| 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association … KA Hicks, JE Tcheng, B Bozkurt, BR Chaitman, DE Cutlip, A Farb, ... Journal of the American College of Cardiology 66 (4), 403-469, 2015 | 918 | 2015 |
| Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American … BM Demaerschalk, DO Kleindorfer, OM Adeoye, AM Demchuk, JE Fugate, ... Stroke 47 (2), 581-641, 2016 | 854* | 2016 |
| Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times … GC Fonarow, EE Smith, JL Saver, MJ Reeves, DL Bhatt, ... Circulation 123 (7), 750-758, 2011 | 776 | 2011 |
| Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment Z Ismail, EE Smith, Y Geda, D Sultzer, H Brodaty, G Smith, L Agüera-Ortiz, ... Alzheimer's & Dementia 12 (2), 195-202, 2016 | 762* | 2016 |
| Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative GC Fonarow, X Zhao, EE Smith, JL Saver, MJ Reeves, DL Bhatt, Y Xian, ... Jama 311 (16), 1632-1640, 2014 | 714 | 2014 |
| Vascular dysfunction—the disregarded partner of Alzheimer's disease MD Sweeney, A Montagne, AP Sagare, DA Nation, LS Schneider, ... Alzheimer's & Dementia 15 (1), 158-167, 2019 | 673 | 2019 |
| A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System H Ay, T Benner, E Murat Arsava, KL Furie, AB Singhal, MB Jensen, ... Stroke 38 (11), 2979-2984, 2007 | 658 | 2007 |
| Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes D Dowlatshahi, AM Demchuk, ML Flaherty, M Ali, PL Lyden, EE Smith Neurology 76 (14), 1238-1244, 2011 | 650 | 2011 |
| Get With the Guidelines–Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack LH Schwamm, GC Fonarow, MJ Reeves, W Pan, MR Frankel, EE Smith, ... Circulation 119 (1), 107-115, 2009 | 648 | 2009 |
| Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage SM Greenberg, JA Eng, MM Ning, EE Smith, J Rosand Stroke 35 (6), 1415-1420, 2004 | 620 | 2004 |
| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, ... The Lancet 395 (10227), 878-887, 2020 | 582 | 2020 |
| Imaging of amyloid burden and distribution in cerebral amyloid angiopathy KA Johnson, M Gregas, JA Becker, C Kinnecom, DH Salat, EK Moran, ... Annals of Neurology: Official Journal of the American Neurological …, 2007 | 580 | 2007 |
| Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis Z Ismail, H Elbayoumi, CE Fischer, DB Hogan, CP Millikin, T Schweizer, ... JAMA psychiatry 74 (1), 58-67, 2017 | 575 | 2017 |
| Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score NS Rost, EE Smith, Y Chang, RW Snider, R Chanderraj, K Schwab, ... Stroke 39 (8), 2304-2309, 2008 | 574 | 2008 |
| Cerebral microinfarcts: the invisible lesions EE Smith, JA Schneider, JM Wardlaw, SM Greenberg The Lancet Neurology 11 (3), 272-282, 2012 | 573 | 2012 |
Lee Schwamm, MDProfessor of Neurology and Bioinformatics and Data Sciences, Yale School of Medicineایمیل تأیید شده در mgh.harvard.edu